MindRank Partners with 3SBio to Commercialize its AI-Designed Oral GLP-1 in China

HANGZHOU, China, Sept. 28, 2026 (GLOBE NEWSWIRE) — MindRank AI Ltd. (“MindRank”) today announced that it has entered into a strategic commercialization agreement with Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd. (“Mandi”) and Zhejiang Wansheng Pharmaceutical Co., Ltd. (“Wansheng”), both subsidiaries of 3SBio Inc. (01530.HK) group, for MDR-001, an AI-designed oral small-molecule GLP-1 receptor agonist in a […]